Business Wire

CHRYSO

Share
CHRYSO and CONDAT Technology Partnership in TBM Tunneling - Preview at AFTES 2021

CHRYSO, a leader in Construction chemicals, today announced a technology partnership with CONDAT. As CONDAT is a world expert in sealing, lubricants and ground treatment formulations for Tunnel Boring Machines (TBM), CHRYSO has joined forces with the company to develop a unique know-how in TBM tunneling applications combined with a scientific expertise of organo-mineral chemistry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210831005617/en/

The first technology issued from this collaboration is a cutting-edge patented backfill grout solution CHRYSO®TBM SGS (Smart Grout System) . The combined use of CHRYSO®TBM SGS 150 retarder and CHRYSO®TBM SGS 400 stabilizer ensure exceptional grout stability over several days. The grout stability and low viscosity allow for pumping over long distance and reduce the need for pipes flushing during machine stoppages, delivering unparalleled performance to meet the most demanding jobsites.

“We are bringing a high-performing environmentally-friendly backfill grout for tunnels and underground cities projects,” said Marc Plançon – Concrete Business Unit Deputy Director at CHRYSO.

CHRYSO®TBM SGS presents many advantages that significantly reduce tunneling construction site’s environmental footprint. The Stabilizer’s unique formulation allows to completely substitute bentonite, a non-renewable raw material commonly used in the backfill mix design. No more bentonite storing neither transport will also contribute to a better environmental management of the site.

“Furthermore, we offer a sustainable supply with our CHRYSO®TBM SGS 400 stabilizer which is based on renewable raw materials (bio-sourcing) and the possibility to use alternate cementitious materials such as GGBS (slag) for a reduced CO2 footprint. Our research plan is totally focused on providing sustainable solutions to our customers and lowering CO2 emissions,” added Marc Plançon.

“Combining support expertise and a worldwide network of laboratories and specialists of both CHRYSO and CONDAT ensures that our customers have access to a reinforced level of local service. This first collaboration on the Smart Grout System has given significant results and we are looking forward to further successful development of innovative solutions," said Thierry SANNA, Sales Director -Tunneling Division at CONDAT.

The two companies will showcase the new CHRYSO®TBM SGS solution at the upcoming AFTES 2021 event ”The underground, a space of innovation” in September in Paris.

> CHRYSO: booth n°133
> CONDAT: booths N°131 et 132

About CHRYSO: https://www.chryso.com/about-us/

About CONDAT: https://www.condat-lubricants.com/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production12.1.2026 13:00:00 CET | Press release

Definitive agreement secures 100% of Phase 1 production, advancing project toward final investment decision Lilac Solutions, a leading provider of direct lithium extraction technology, and Traxys North America, a leading global physical trader and merchant in metals and natural resources, today announced a binding 10-year offtake agreement for lithium carbonate produced at Lilac's Great Salt Lake facility in Utah. The agreement represents a major milestone in advancing the project toward construction and establishes a clear commercial pathway for one of the nearest-term domestic lithium projects in the United States. Under the terms of the definitive agreement, Traxys will purchase 50,000 tonnes of lithium carbonate over a 10-year period, representing 100% of the planned Phase 1 production capacity. The agreement is take-or-pay, with agreed pricing mechanisms linked to market indices. The Great Salt Lake Phase 1 facility is designed to produce 5,000 tonnes per annum of battery-grade li

Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,

Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release

Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP

Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release

Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through

Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse

Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye